Geisinger Health System recently launched an online portal that allows patients to contribute their own genomic data, which in turn will be analyzed by the NIH-funded Clinical Genome Resource. The Pennsylvania-based health system and its researches developed the portal, GenomeConnect, that will connect with the NIH effort to gather and analyze data from “thousands of […]
The desire by patients to take control of their data combined with the growth of personalized medicine raises an interesting question? What’s the best way for doctors to give patients genetic test results? Readmission is also a vexing issue, particularly for COPD. What kind of insights could patients offer doctors to change how they provide […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Geisinger Health System is launching a partnership with Indivumed to bank and quickly preserve samples from consenting cancer patients undergoing surgical tumor removal. A developer for individualized oncology technology, Indivumed will help the hospital system gather samples and strengthen its data collection efforts. The partnership will permit Indivumed, based in Hamburg, Germany, to collect and […]
Esophageal cancer is one of the fastest growing cancers in western countries and has one of the highest mortality rates among cancers. About 17,990 new cases are diagnosed in the United States each year, according to data from the American Cancer Society. More than 15,000 people die from esophageal cancer annually. Medical device company Cernostics […]
Update It could have been the setting in Vero Beach, Fla., or that in his support of the law he acknowledged many of its flaws. But Geisinger Health System CEO Dr. Glenn Steele along with teammate Partners Healthcare CEO Dr. Gary Gottlieb failed to convince an audience assembled at Riverside Theater that The Nation Needs […]
Geisinger Health System announced this week that it’s working with Regeneron Pharmaceuticals (NASDAQ: REGN) in a project to use genetic samples from more than 100,000 volunteers to identify and validate associations between genes and human disease. The move reflects Geisinger’s efforts to advance genomic analysis from the research stage to the point where it is […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Geisinger Health System’s spinout company, xG Health Solutions, may be looking for provider customers for its healthcare analytics tools and consulting business to help them convert from fee-based to outcomes-based care, but it’s pretty selective. In a presentation to a packed crowd at the JP Morgan Healthcare conference, its CEO Dr Earl Steinberg said: “We […]